564 related articles for article (PubMed ID: 10202050)
21. Response to immunization against polio after allogeneic marrow transplantation.
Ljungman P; Duraj V; Magnius L
Bone Marrow Transplant; 1991 Feb; 7(2):89-93. PubMed ID: 1646664
[TBL] [Abstract][Full Text] [Related]
22. Comparative evaluation of immunization with live attenuated and inactivated poliovirus vaccines.
Ogra PL
Ann N Y Acad Sci; 1995 May; 754():97-107. PubMed ID: 7625685
[TBL] [Abstract][Full Text] [Related]
23. [The perspective of global eradication of poliomyelitis].
Knolle H; Egli A; Candrian U
Gesundheitswesen; 2004 Jan; 66(1):1-6. PubMed ID: 14767784
[TBL] [Abstract][Full Text] [Related]
24. Long-term evaluation of mucosal and systemic immunity and protection conferred by different polio booster vaccines.
Xiao Y; Daniell H
Vaccine; 2017 Sep; 35(40):5418-5425. PubMed ID: 28111147
[TBL] [Abstract][Full Text] [Related]
25. Booster immunization with a hexavalent diphtheria, tetanus, acellular pertussis, hepatitis B, inactivated poliovirus vaccine and Haemophilus influenzae type b conjugate combination vaccine in the second year of life: safety, immunogenicity and persistence of antibody responses.
Heininger U; ; ; Sänger R; Jacquet JM; Schuerman L
Vaccine; 2007 Jan; 25(6):1055-63. PubMed ID: 17049692
[TBL] [Abstract][Full Text] [Related]
26. Combined immunization of infants with oral and inactivated poliovirus vaccines: results of a randomized trial in The Gambia, Oman, and Thailand. WHO Collaborative Study Group on Oral and Inactivated Poliovirus Vaccines.
Bull World Health Organ; 1996; 74(3):253-68. PubMed ID: 8789924
[TBL] [Abstract][Full Text] [Related]
27. Evaluation of immunogenicity and protective properties of inactivated poliovirus vaccines: a new surrogate method for predicting vaccine efficacy.
Dragunsky EM; Ivanov AP; Wells VR; Ivshina AV; Rezapkin GV; Abe S; Potapova SG; Enterline JC; Hashizume S; Chumakov KM
J Infect Dis; 2004 Oct; 190(8):1404-12. PubMed ID: 15378432
[TBL] [Abstract][Full Text] [Related]
28. Neonatal sublingual vaccination with Salmonella proteins and adjuvant cholera toxin or CpG oligodeoxynucleotides induces mucosal and systemic immunity in mice.
Huang CF; Wang CC; Wu TC; Wu KG; Lee CC; Peng HJ
J Pediatr Gastroenterol Nutr; 2008 Mar; 46(3):262-71. PubMed ID: 18376242
[TBL] [Abstract][Full Text] [Related]
29. Determination of poliovirus-specific IgA in saliva by ELISA tests.
Ivanov A; Dragunsky E; Ivanova O; Rezapkin G; Potapova S; Chumakov K
J Virol Methods; 2005 Jun; 126(1-2):45-52. PubMed ID: 15847918
[TBL] [Abstract][Full Text] [Related]
30. Comparative evaluation of immunization with live attenuated and enhanced-potency inactivated trivalent poliovirus vaccines in childhood: systemic and local immune responses.
Faden H; Modlin JF; Thoms ML; McBean AM; Ferdon MB; Ogra PL
J Infect Dis; 1990 Dec; 162(6):1291-7. PubMed ID: 2172403
[TBL] [Abstract][Full Text] [Related]
31. Intestinal immunity is a determinant of clearance of poliovirus after oral vaccination.
Wright PF; Wieland-Alter W; Ilyushina NA; Hoen AG; Arita M; Boesch AW; Ackerman ME; van der Avoort H; Oberste MS; Pallansch MA; Burton AH; Jaffar MA; Sutter RW
J Infect Dis; 2014 May; 209(10):1628-34. PubMed ID: 24459191
[TBL] [Abstract][Full Text] [Related]
32. A comparative study of reactogenicity and immunogenicity of an oral and an inactivated polio vaccine.
Borcić B; Dobrovsak-Sourek V; Kaić B; Ljubicić M
Acta Med Croatica; 1998; 52(3):155-8. PubMed ID: 9818437
[TBL] [Abstract][Full Text] [Related]
33. Mucosal immunization of CD4+ T cell-deficient mice with an inactivated virus induces IgG and IgA responses in serum and mucosal secretions.
Sha Z; Kang SM; Compans RW
Virology; 2005 Jan; 331(2):387-95. PubMed ID: 15629781
[TBL] [Abstract][Full Text] [Related]
34. Further development of a new transgenic mouse test for the evaluation of the immunogenicity and protective properties of inactivated poliovirus vaccine.
Dragunsky EM; Ivanov AP; Abe S; Potapova SG; Enterline JC; Hashizume S; Chumakov KM
J Infect Dis; 2006 Sep; 194(6):804-7. PubMed ID: 16941347
[TBL] [Abstract][Full Text] [Related]
35. Intestinal immunity following a combined enhanced inactivated polio vaccine/oral polio vaccine programme in Israel.
Swartz TA; Green MS; Handscher R; Sofer D; Cohen-Dar M; Shohat T; Habib S; Barak E; Dror Z; Somekh E; Peled-Leviathan T; Yulzari R; Libling A; Mendelson E; Shulman LM
Vaccine; 2008 Feb; 26(8):1083-90. PubMed ID: 18241962
[TBL] [Abstract][Full Text] [Related]
36. Randomized comparison of early and late vaccination with inactivated poliovirus vaccine after allogeneic BMT.
Parkkali T; Stenvik M; Ruutu T; Hovi T; Volin L; Ruutu P
Bone Marrow Transplant; 1997 Oct; 20(8):663-8. PubMed ID: 9383230
[TBL] [Abstract][Full Text] [Related]
37. Nasopharyngeal secretory antibody response to poliovirus type 3 virion proteins exhibit different specificities after immunization with live or inactivated poliovirus vaccines.
Zhaori G; Sun M; Faden HS; Ogra PL
J Infect Dis; 1989 Jun; 159(6):1018-24. PubMed ID: 2470831
[TBL] [Abstract][Full Text] [Related]
38. Effect of a single inactivated poliovirus vaccine dose on intestinal immunity against poliovirus in children previously given oral vaccine: an open-label, randomised controlled trial.
John J; Giri S; Karthikeyan AS; Iturriza-Gomara M; Muliyil J; Abraham A; Grassly NC; Kang G
Lancet; 2014 Oct; 384(9953):1505-12. PubMed ID: 25018120
[TBL] [Abstract][Full Text] [Related]
39. A mucosal adjuvant for the inactivated poliovirus vaccine.
Steil BP; Jorquera P; Westdijk J; Bakker WA; Johnston RE; Barro M
Vaccine; 2014 Jan; 32(5):558-63. PubMed ID: 24333345
[TBL] [Abstract][Full Text] [Related]
40. Different secretory IgA antibody responses after immunization with inactivated and live poliovirus vaccines.
Hanson LA; Carlsson B; Jalil F; Lindblad BS; Khan SR; van Wezel AL
Rev Infect Dis; 1984; 6 Suppl 2():S356-60. PubMed ID: 6740073
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
